Single dexamethasone injection increases alveolar fluid clearance in adult rats

Crit Care Med. 2003 Apr;31(4):1183-9. doi: 10.1097/01.CCM.0000059640.77535.29.

Abstract

Objective: Epithelial Na+ channels and Na+/K+-adenosine triphosphatase (ATPase) in alveolar epithelium have a very important role in the absorption of excessive fluid from the alveolar space. We examined whether single dexamethasone injection at therapeutic doses would modulate lung epithelial Na+ channels and Na+/K+-ATPase and increase alveolar fluid clearance in adult rats.

Design: Controlled laboratory study.

Setting: University research laboratory.

Subjects: Adult male Sprague-Dawley rats (n = 138).

Interventions: Rats were intraperitoneally injected with dexamethasone at a dose ranging from 0.02 to 2.0 mg/kg, and allowed free access to food and water.

Measurements and main results: Alveolar fluid clearance was determined by measuring the increase in albumin concentration in the lung instillate solution. We discovered a significant increase in alveolar fluid clearance at 48 and 72 hrs after dexamethasone treatment. The effect of dexamethasone was dose dependent. In addition, increased alveolar fluid clearance was associated with a faster recover from hypoxemia, which was induced by filling the alveolar space with instillate solution. The dexamethasone-induced increase in alveolar fluid clearance was inhibited by amiloride and ouabain. Quantitative reverse transcriptase-polymerase chain reaction showed that dexamethasone treatment increased lung beta-epithelial Na+ channel mRNA levels. The expression of gamma-epithelial Na+ channel mRNA was also increased slightly. In contrast, alpha-epithelial Na+ channel mRNA levels did not differ from control levels. There was no change in alpha1- or beta1-Na+/K+-ATPase mRNA levels over 72 hrs after dexamethasone treatment. However, we found that lung Na+/K+-ATPase hydrolytic activity, determined by monitoring the ouabain-sensitive ATPase hydrolysis, was increased at 48 and 72 hrs after dexamethasone treatment.

Conclusions: Single dexamethasone injection at therapeutic doses is capable of modulating lung epithelial Na+ channels and Na+/K+-ATPase and increase alveolar fluid clearance, thereby accelerating recovery from pulmonary edema.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dexamethasone / administration & dosage*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Epithelium / metabolism
  • Extravascular Lung Water / metabolism*
  • Glucocorticoids / administration & dosage*
  • Injections, Intraperitoneal
  • Male
  • Ouabain / pharmacology
  • Pulmonary Alveoli / metabolism*
  • Pulmonary Edema / drug therapy*
  • Pulmonary Edema / metabolism
  • RNA, Messenger / analysis
  • Rats
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sodium Channels / genetics
  • Sodium Channels / metabolism
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors
  • Sodium-Potassium-Exchanging ATPase / metabolism

Substances

  • Enzyme Inhibitors
  • Glucocorticoids
  • RNA, Messenger
  • Sodium Channels
  • Ouabain
  • Dexamethasone
  • Sodium-Potassium-Exchanging ATPase